EGFR Mutation Analysis in Non-small Cell Lung Carcinoma Patients: A Liquid Biopsy Approach

In conclusion, our data suggest that evaluation ofEGFR mutation from cfDNA samples is practicable as a non-invasive tool in patients with advanced-stage of lung cancer.
Source: Indian Journal of Clinical Biochemistry - Category: Biochemistry Source Type: research